Mainstream

Vanda Pharmaceuticals Targets $1b Revenue By 2030 With Expanded Psychiatry Portfolio

Vanda Pharmaceuticals targets $1B revenue by 2030 with expanded psychiatry portfolio

Vanda Pharmaceuticals targets $1B revenue by 2030 with expanded psychiatry portfolio

Post ContentvndaRead More

You might also be interested in reading Aussie crypto companies keen to embrace regulations says senator.

February 14, 2025
In Mainstream